Shaw S, DeMars R, Schlossman S F, Smith P L, Lampson L A, Nadler L M
J Exp Med. 1982 Sep 1;156(3):731-43. doi: 10.1084/jem.156.3.731.
The secondary B cell (SB) antigens are polymorphic HLA-linked antigens on human B cells and macrophages that are identified by primed T cell responses but are genetically distinct from the HLA-DR, MB, and MT antigens. Serologic identification of the SB molecule, using the monoclonal antibody ILR1, now makes it possible to correlate the function of these determinants in human T cell recognition with an Ia-like molecular structure and a genetic locus that marks a new HLA subregion. Three lines of evidence indicate that the ILR1 molecule identifies an epitope on some alleles of the SB gene: (a) the polymorphism of ILR1 -reactivity in the population correlates with SB2 SB3; (b) T cell proliferative response to SB2 and SB3 are specifically inhibited by ILR1; and (c) ILR1 reactivity is exactly concordant with the expression of SB2 in a panel of HLA-deletion mutant lymphoblastoid cell line. Together with previous studies, these results indicate that the SB antigens are on Ia-like molecules. Furthermore, the serologic studies of HLA-deletion mutant cell lines demonstrate that there are two HLA regions centromeric to HLA-B controlling expression of Ia-like molecules: a region toward HLA-B that controls expression of HLA-DR, and a region toward GLO that controls expression of SB.
次要B细胞(SB)抗原是人类B细胞和巨噬细胞上的多态性HLA连锁抗原,可通过致敏T细胞反应识别,但在基因上与HLA-DR、MB和MT抗原不同。使用单克隆抗体ILR1对SB分子进行血清学鉴定,现在使得将这些决定簇在人类T细胞识别中的功能与Ia样分子结构和标记新HLA亚区的基因座相关联成为可能。三条证据表明ILR1分子识别SB基因某些等位基因上的一个表位:(a)人群中ILR1反应性的多态性与SB2、SB3相关;(b)对SB2和SB3的T细胞增殖反应被ILR1特异性抑制;(c)在一组HLA缺失突变淋巴母细胞系中,ILR1反应性与SB2的表达完全一致。与先前的研究一起,这些结果表明SB抗原存在于Ia样分子上。此外,对HLA缺失突变细胞系的血清学研究表明,在HLA-B着丝粒方向有两个HLA区域控制Ia样分子的表达:一个朝向HLA-B的区域控制HLA-DR的表达,一个朝向GLO的区域控制SB的表达。